SAN CARLOS, CA, March 4, 2024 -- Glycomine, Inc., a biotechnology company focused on developing new therapies for orphan diseases, announced the presentation of summary findings from its ongoing Phase...
Athersys begins Phase I trial for ATHX-105 for treatment of obesity
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.